Navigation Links
InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Date:3/15/2013

TEL-AVIV, Israel, March 15, 2013 /PRNewswire/ --

InspireMD's Carotid Embolic Protection Stent, based on InspireMD's proprietary MicroNet[TM] mesh technology, is designed to provide procedural and post-procedural distal embolic protection in Carotid Artery Stenting(CAS) procedures and there by reduce risk of stroke events.

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ Embolic Protection Stent (EPS), announced today that the Company received CE mark approval this morning for its self-expanding Nitinol carotid EPS.  This carotid embolic protection stent is based on the proprietary MicroNet[TM] mesh protection platform technology used to treat heart attack patients with InspireMD's commercially available coronary EPS stents, MGuard[TM] and MGuard Prime[TM].  

When treating carotid arterial disease, close to half of Carotid Artery Stenting (CAS) procedures cause distal embolic events that may lead to stroke within 30 days.  The InspireMD Carotid Embolic Protection Stent (EPS) is wrapped with a MicroNet[TM] mesh to prevent embolic events during and post CAS procedure.  The MicroNet[TM] is designed to hold plaque and thrombus in place against the wall of the blocked artery, preventing debris from falling into the bloodstream and causing a potentially fatal downstream blockage or stroke.

In coronary procedures, InspireMD's EPS technology has already shown improvements through the MASTER trial findings that revealed a statistically and clinically significant acute advantage of MGuard EPS with regard to ST segment resolution. As a resul
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
2. InspireMD Reports Results for Period Ended Dec. 31, 2012
3. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
4. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
5. InspireMD Reports Results For Period Ending Sept. 30, 2012
6. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
7. InspireMD to Present at Harvard Investors Group on June 27 in New York
8. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
9. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
10. InspireMD Announces First Quarter 2012 Financial Results
11. Cardium Receives ISO Certification for Excellagen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Reportlinker.com announces that a new market research report is ... Pharmaceutical Packaging Market http://www.reportlinker.com/p0288103/US-Pharmaceutical-Packaging-Market.html ... 5.5% annually through 2014 Demand for ... increase 5.5 percent annually to $18.4 billion in 2014. ...
... Inc. (PSI), a leading pharmaceutical Contract Research Organization ... to help advance early stage molecules and drug ... Under the established framework between Children,s and PSI, ... at progressing the specific drug or drug product ...
Cached Medicine Technology:Reportlinker Adds US Pharmaceutical Packaging Market 2Reportlinker Adds US Pharmaceutical Packaging Market 3Reportlinker Adds US Pharmaceutical Packaging Market 4Reportlinker Adds US Pharmaceutical Packaging Market 5Reportlinker Adds US Pharmaceutical Packaging Market 6Reportlinker Adds US Pharmaceutical Packaging Market 7Reportlinker Adds US Pharmaceutical Packaging Market 8Reportlinker Adds US Pharmaceutical Packaging Market 9Reportlinker Adds US Pharmaceutical Packaging Market 10Children's Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Deer Path of ... host a Valentine’s Day Happy Hour from 3 p.m. to 4 ... 12500 Regency Parkway in Huntley, Illinois, serves adults with physical disabilities ... event will include Valentine's Day treats, games and sweetheart-themed karaoke. , ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... of childhood cancer survivors who received prior treatment involving ... agents do not have an increased risk for birth ... have such cancer treatment. The findings provide reassurance that ... survivors who are concerned about the potential effects of ...
... HealthDay Reporter , MONDAY, Dec. 12 (HealthDay News) -- Young ... do not seem to face an increased risk for cardiovascular ... that these drugs can cause increases in heart rate and ... that these effects posed a risk, the researchers said. ...
... Athens, Ga.Researchers from the University of Georgia and the Mayo ... tumors in a mouse model that mimics 90 percent of ... to common treatments. The vaccine, described this ... of the National Academy of Sciences , reveals a promising ...
... December 12, 2011. Researchers from the University of Maryland ... launched a study of exercise and computerized memory training to ... prevent memory changes. The type of memory that will be ... take in information and use it in a new way. ...
... ways to halt the uncontrolled growth of cancer cells, scientists ... drugs, called PARP inhibitors, may block the ability of pre-leukemic ... these cells to self-destruct. Results of their experiments, expected ... American Society of Hematology in San Diego, Dec. 12, have ...
... 12, 2011) -- A new study finds that patients who ... twice as likely to develop delirium, a potentially dangerous change ... began their stay in isolation were not at increased risk. ... Infection Control and Hospital Epidemiology, the journal of the ...
Cached Medicine News:Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 2Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 3Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 4Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 2Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 3Health News:Scientists develop vaccine that attacks breast cancer in mice 2Health News:Scientists develop vaccine that attacks breast cancer in mice 3Health News:Scientists develop vaccine that attacks breast cancer in mice 4Health News:Exercise/memory research for Parkinson's 2Health News:Exercise/memory research for Parkinson's 3Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 2Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 3Health News:Patient isolation associated with hospital delirium: study 2
...
...
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
Medicine Products: